Healthtech products
We develop focused digital health products for problems that are clinically important, operationally difficult and poorly served by generic technology.
Key focus areas
Improving how clinical conversations are trained, assessed and reviewed, including person-centered language, clarity, collaboration and stigma-sensitive communication.
Supporting earlier recognition of situations in which treatment initiation or intensification may be delayed despite an identified clinical need.
Using structured clinical information to identify preventable risks earlier and support more timely action.
A patented clinical communication intelligence platform that analyzes observable features of clinical talk and converts them into specific, actionable feedback for training, assessment and improvement.
Explore ConversationAIlyPerson-centered language, collaboration, clarity, acknowledgment and conversational balance.
Specific communication patterns and alternatives rather than a single generic score.
Training, continuing professional development and selected clinical-use workflows.
Longitudinal indicators and dashboards for program- and institution-level learning.
In development
We are developing additional healthtech solutions around treatment progression, risk identification and earlier clinical action. These concepts remain in development and will be introduced only when they reach an appropriate level of validation and readiness.
Structured review of clinical indicators that may suggest a need to reassess treatment intensity or timing.
Identification of selected patterns that may warrant earlier clinical review, follow-up or preventive action.
Collaborative innovation
Define the clinical or operational problem precisely.
Set the evidence, workflow and success criteria.
Build and refine with intended users.
Integrate into the relevant setting or workflow.
Measure performance, adoption and opportunities for improvement.
FAQ
ConversationAIly is SigmaMozak’s developed flagship platform. Two additional products are currently in development, focused on treatment progression and risk identification.
SigmaMozak products are designed to support both individual users and institutional programs. Individual clinicians and learners can use them for structured feedback and reflection, while institutions can use the same underlying platform for training, assessment, implementation monitoring and aggregate learning.
Yes. We welcome opportunities to co-develop digital health solutions with healthcare organizations, academic institutions and other partners. The strongest collaborations usually begin with a clearly defined clinical or operational problem, followed by joint development, validation and implementation planning.